References
- Nicola M, Alsafi Z, Sohrabi C, et al. The socio-economic implications of the coronavirus pandemic (COVID-19): a review. Int J Surg. 2020;78:185–193.
- John Hopkins University & Medicine. Mortality Analysis. 2020. https://coronavirus.jhu.edu/data/mortality. Accessed September 24, 2020.
- Centers for Disease Control and Prevention. COVID-19 Testing Overview. https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/testing-in-us.html. Accessed August 25, 2020.
- Schmitt-Grohé S, Teoh K, Uribe M, COVID-19: Testing Inequality in New York City. 2020. National Bureau of Economic Research Working Paper Series.
- Liang L-L, Tseng C-H, Ho HJ, Wu C-Y. Covid-19 mortality is negatively associated with test number and government effectiveness. Sci Rep. 2020;10(1):12567.
- Guest JL, Rio CD, Sanchez T. The three steps needed to end the COVID-19 pandemic: bold public health leadership, rapid innovations, and courageous political will. JMIR Public Health Surveill. 2020;6(2):e19043.
- Earnshaw VA, Brousseau NM, Hill EC, Kalichman SC, Eaton LA, Fox AB. Anticipated stigma, stereotypes, and COVID-19 testing. Stigma and Health. 2020;5(4):390–393.
- Figueroa C, Johnson C, Ford N, et al. Reliability of HIV rapid diagnostic tests for self-testing compared with testing by health-care workers: a systematic review and meta-analysis. The Lancet HIV. 2018;5(6):e277–e290.
- United States Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization to Yale School of Public Health for SalivaDirect, Which Uses a New Method of Saliva Sample Processing. 2020; https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-yale-school-public-health. Accessed November 2, 2020.
- Centers for Disease Control and Prevention. People Who Need to Take Extra Precautions. 2020. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/index.html. Accessed July 6, 2020.
- Centers for Disease Control and Prevention. People of Any Age with Underlying Medical Conditions. 2020. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html. Accessed July 6, 2020.
- Volkow ND. Collision of the COVID-19 and addiction epidemics. Ann Intern Med. 2020;173(1):61–62.
- Schimmel J, Manini AF. Opioid use disorder and COVID-19: biological plausibility for worsened outcomes. Subst Use Misuse. 2020;55(11):1900–1901.
- Sanborn V, Gunstad J, Shrestha R, Mistler CB, Copenhaver MM. Cognitive profiles in persons with opioid use disorder enrolled in methadone treatment. Applied Neuropsychology: Adult. 2020;2020:1–7.
- National Institute on Drug Abuse. Addressing the Unique Challenges of COVID-19 for People in Recovery. 2020. https://www.drugabuse.gov/about-nida/noras-blog/2020/09/addressing-unique-challenges-covid-19-people-in-recovery. Accessed September 22, 2020.
- LeSaint KT, Snyder HR. Impact of social distancing on individuals who use drugs: considerations for emergency department providers. West J Emerg Med. 2020;21(5):1102–1104.
- Henry BF, Mandavia AD, Paschen-Wolff MM, et al. COVID-19, mental health, and opioid use disorder: old and new public health crises intertwine. Psychol Trauma Theory Res Prac Policy. 2020;12(S1):S111–S112.
- Muncan B, Walters SM, Ezell J, Ompad DC. They look at us like junkies: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduct J. 2020;17(1):53.
- Davis CS, Samuels EA. Opioid policy changes during the COVID-19 pandemic – and beyond. J Addict Med. 2020;14(4):e4–e5.
- Shrestha R, DiDomizio EE, Kim RS, et al. Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs. J Subst Abuse Treat. 2020;117:108058.
- IBM Corporation, IBM SPSS Statistics for Windows. Armonk, NY: IBM Corp.; 2017.
- Paquette CE, Syvertsen JL, Pollini RA. Stigma at every turn: health services experiences among people who inject drugs. Int J Drug Policy. 2018;57:104–110.
- Sarang A, Rhodes T, Sheon N. Systemic barriers accessing HIV treatment among people who inject drugs in Russia: a qualitative study. Health Policy Plan. 2013;28(7):681–691.
- Oesterle TS, Kolla B, Risma CJ, et al. Substance use disorders and telehealth in the COVID-19 pandemic era: a new outlook. Mayo Clin Proc. 2020;95(12):2709–2718.
- Drake C, Yu J, Lurie N, et al. Policies to improve substance use disorder treatment with telehealth during the COVID-19 pandemic and beyond. J Addict Med. 2020;14(5):e139–e141.